Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jounce Gets $261m To Start, Milestone Fees Up To $2.3bn In Celgene Deal

Executive Summary

A deal with Celgene Corp. worth $261m up front will save Jounce Therapeutics Inc. from having to wade into the treacherous market for initial public offerings in order to advance and accelerate its immuno-oncology research and development programs.

Advertisement

Related Content

Start-Up Quarterly Statistics: Early Funding Declined, But Deal Dollars Flowed
IPO Update: Three Biopharma Offerings In January Contrast With Last Year’s Slow Start
Biopharma Quarterly Dealmaking Statistics, Q3 2016
Start-Up Quarterly Statistics, Q3 2016
2Q Preview: GSK, Bayer, Celgene, Amgen, AZ, BMS, Sanofi, Merck, Abbvie
Deal Watch: Galenica Offers For Relypsa, But Other Suitors May Emerge
Venture Funding Deals, May 2015
Jounce's Immunotherapy Recruiting Coup
Third Rock rolls $47m dice on cancer immunotherapy and Jounce 'dream team'

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC096928

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel